World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 27 May 2013
Main ID:  NTR86
Date of registration: 05/08/2005
Primary sponsor: Academic Medical Center (AMC)
Public title: Randomized study of Early Assessment by CT scanning in Trauma patients.
Scientific title: A randomized comparison of the bi-located Traumacenter North-West Netherlands, evaluating the presence of a Shockroom CT scanner on patient outcome and operations research. - REACT Trial
Date of first enrolment: 1/11/2005
Target sample size: 1124
Recruitment status: complete
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=86
Study type:  intervention
Study design:  Randomised: Yes; Masking: None; Control: Active; Group: Parallel; Type: 2 or more arms, randomized  
Countries of recruitment
The Netherlands
Contacts
Name: J.C.  Goslings
Address:  Academic Medical Center (AMC), G4-105, P.O. Box 22660 , Meibergdreef 9 1100 DD Amsterdam The Netherlands
Telephone: +31 (0)20 5666019
Email: j.c.goslings@amc.uva.nl
Affiliation: 
Name: J.C.  Goslings
Address:  Academic Medical Center (AMC), G4-105, P.O. Box 22660 , Meibergdreef 9 1100 DD Amsterdam The Netherlands
Telephone: +31 (0)20 5666019
Email: j.c.goslings@amc.uva.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: All patients that are transported to the AMC or VUmc shockroom according to current pre-hospital triage system based on:

1. Injury mechanism;

2. Revised Trauma Score;

3. Presence or absence of traumatic brain injury.

Exclusion criteria: Excluded from analysis and comparison are:

1. Patients younger than 16 years of age;

2. Death during transport to the hospital.



Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Trauma

Intervention(s)
Patients are transported to either the VUmc or the AMC, based on randomization. Trauma care will remain the same for both institutions, with the only difference the location of the CT scanner.
Primary Outcome(s)
The number of days spent outside the hospital in the first year following the emergency admission in the shockroom will be our primary outcome. This outcome is responsive to differences in mortality (no more/additional days outside hospital), to differences in hospital stay for the initial admission, to differences in readmission rate (i.e. because of missed diagnoses).
Furthermore, there is a positive association between a shorter hospital stay and better functional health. Care will be given to harmonize discharge criteria between the two hospitals.
Secondary Outcome(s)
The secondary outcome parameters for the patient outcome part of the study will focus on:

1. The process of care parameters of the initial admission. This will include the comparison of various time intervals relevant in trauma care:

1.1 time to obtain results of CT imaging;

1.2 time to operation or other interventions (door-to-treatment time);

1.3 time to active bleed managing;

1.4 time to definitive care facility (ICU, high care, nursing ward);

1.5 duration of intensive care treatment;

1.6 time to discharge from the hospital;

2. Radiological examinations and findings:

2.1 The frequency and type of radiological examinations in each strategy;

2.2 description of the number, type and severity of diagnoses categorized by imaging modality in each strategy;

3. General health. This will be measured in all patients at 6 and 12 months after the shockroom admission using the EuroQol and HUI3 questionnaires;

4. All-cause mortality. This will include both in-hospital mortality and mortality during the first year following the trauma;

5. Radiation dose. The mean radiation dose will be calculated in both strategies based on the actual number and type of radiological examinations related to the initial trauma performed in each patient during the first year.
Secondary ID(s)
3920.0005
ISRCTN55332315
Source(s) of Monetary Support
ZON-MW, The Netherlands Organization for Health Research and Development
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history